NCT01222455View on ClinicalTrials.gov

A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Hepatic ImpairmentHealthy VolunteersPharmacokineticsAmount of R406 in Blood

Interventions

DRUG

Fostamatinib

Oral tablets, single dose

Trial Locations (1)

Unknown

Research Site, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY